Primary Site >> Pancreatic Cancer
Gene >> VEGFC
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. PMID: 11291931 Ref: Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. PMID: 11332691 Ref: Interaction of rat tumor cells with blood vessels and lymphatics of the avian chorioallantoic membrane. PMID: 11596155 |
Ref: Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. PMID: 15166270 Ref: Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. PMID: 15501970 Ref: Impact of vascular endothelial growth factor-C and -D expression in human pancreatic cancer: its relationship to lymph node metastasis. PMID: 15623620 |
Ref: Osteoclast-like giant cell tumor in mucinous cystadenocarcinoma of the pancreas: an immunohistochemical and molecular analysis. PMID: 15734212 Ref: Interleukin-1alpha, 6 regulate the secretion of vascular endothelial growth factor A, C in pancreatic cancer. PMID: 16109537 |
Ref: Expression of vascular endothelial growth factors A and C in human pancreatic cancer. PMID: 16482630 Ref: Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. PMID: 16525637 Ref: Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer. PMID: 17219968 |
Ref: Effect of antisense oligodeoxynucleotide of vascular endothelial growth factor C on lymphangiogenesis and angiogenesis of pancreatic cancer. PMID: 17393109 |
Ref: CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. PMID: 18349830 Ref: Inhibition of human pancreatic cell line MIA PaCa2 proliferation by HA-But, a hyaluronic butyric ester: a preliminary report. PMID: 18437074 |
Ref: Low molecular weight heparin suppresses lymphatic endothelial cell proliferation induced by vascular endothelial growth factor C in vitro. PMID: 19719950 Ref: [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis]. PMID: 20137690 |
Ref: Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer. PMID: 20367641 Ref: Src tyrosine kinase inhibition suppresses lymphangiogenesis in vitro and in vivo. PMID: 20370688 |
Ref: Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer. PMID: 21685330 |
Ref: The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma. PMID: 22082308 Ref: Analysis of tumor-induced lymphangiogenesis and lymphatic vessel invasion of pancreatic carcinoma in the peripheral nerve plexus. PMID: 22716017 |
Ref: M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. PMID: 22699204 Ref: Everolimus dual effects of an area vasculosa angiogenesis and lymphangiogenesis. PMID: 23239853 Ref: VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model. PMID: 23393331 Ref: Vasohibin-1 expression is regulated by transforming growth factor-beta/bone morphogenic protein signaling pathway between tumor-associated macrophages and pancreatic cancer cells. PMID: 23651239 |
Ref: COUP-TFII in pancreatic adenocarcinoma: clinical implication for patient survival and tumor progression. PMID: 24122412 Ref: KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo. PMID: 24463085 Ref: KML001 inhibits cell proliferation and invasion in pancreatic cancer cells through suppression of NF-kappaB and VEGF-C. PMID: 24982355 Ref: Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas. PMID: 25155377 |
Ref: KML001 enhances anticancer activity of gemcitabine against pancreatic cancer cells. PMID: 25550550 Ref: Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling. PMID: 25909285 Ref: VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature. PMID: 26710495 |
Ref: Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma. PMID: 26893739 Ref: Src/STAT3 signaling pathways are involved in KAI1-induced downregulation of VEGF-C expression in pancreatic cancer. PMID: 27082851 |
Ref: MiR-142 modulates human pancreatic cancer proliferation and invasion by targeting hypoxia-inducible factor 1 (HIF-1alpha) in the tumor microenvironments. PMID: 28069592 |
Ref: Mechanisms by which CXCR4/CXCL12 cause metastatic behavior in pancreatic cancer. PMID: 29434873 |